Literature DB >> 12605893

Neurotoxicity of an endogenous brain amine, 1-benzyl-1,2,3,4-tetrahydroisoquinoline, in organotypic slice co-culture of mesencephalon and striatum.

Y Kotake1, S Ohta, I Kanazawa, M Sakurai.   

Abstract

Organotypic slice co-culture of the ventromedial portion of the mesencephalon and striatum was used to evaluate the neurotoxicity of 1-benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous brain amine related to Parkinson's disease. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline is specifically increased in the cerebrospinal fluid of patients with Parkinson's disease and induces parkinsonian features in the monkey and mouse. Here, it decreased the dopamine content of the cultured mesencephalon in both dose- (10-100 microM) and time- (24 h to 7 days) dependent manners. This result suggests that the neurotoxicity of 1-benzyl-1,2,3,4-tetrahydroisoquinoline is correlated with the overall exposure (concentration multiplied by exposure time). Culture with 100 microM 1-benzyl-1,2,3,4-tetrahydroisoquinoline for 24 h irreversibly reduced the dopamine content. Furthermore, culture with 100 microM 1-benzyl-1,2,3,4-tetrahydroisoquinoline for 10 days caused morphological changes, including cell body shrinkage and distortion of dendritic morphology, in tyrosine hydroxylase-positive cells in the mesencephalon and reduced the number of cells by half. The increase in lactate dehydrogenase activity in the media produced by 1-benzyl-1,2,3,4-tetrahydroisoquinoline was significant in culture of the mesencephalon alone or its co-culture with striatum, but not in cultures of other brain regions. We suggest that 1-benzyl-1,2,3,4-tetrahydroisoquinoline is toxic to tyrosine hydroxylase-positive cells in the ventral mesencephalon and that it is correlated with the integral of the concentration by time of exposure. Thus a low concentration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline may first induce a decrease in the dopamine content then shrinkage of the cell body, followed by the slow death of dopaminergic neurons over a long period. This is the first report that indicates 1-benzyl-1,2,3,4-tetrahydroisoquinoline exerts neurotoxicity at the cellular level, and reveals in part the character of its neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12605893     DOI: 10.1016/s0306-4522(02)00789-3

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

1.  Dopaminergic development of prenatal ventral mesencephalon and striatum in organotypic co-cultures.

Authors:  Gregory D Lyng; Abigail Snyder-Keller; Richard F Seegal
Journal:  Brain Res       Date:  2006-12-28       Impact factor: 3.252

2.  1-Benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous parkinsonism-inducing toxin, strongly potentiates MAO-dependent dopamine oxidation and impairs dopamine release: ex vivo and in vivo neurochemical studies.

Authors:  Agnieszka Wasik; Irena Romańska; Lucyna Antkiewicz-Michaluk
Journal:  Neurotox Res       Date:  2009-02-10       Impact factor: 3.911

3.  Quantification of salsolinol enantiomers by stable isotope dilution liquid chromatography with tandem mass spectrometric detection.

Authors:  Min Cai; Yi-Ming Liu
Journal:  Rapid Commun Mass Spectrom       Date:  2008-12       Impact factor: 2.419

4.  1-Benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous neurotoxic compound, disturbs the behavioral and biochemical effects of L-DOPA: in vivo and ex vivo studies in the rat.

Authors:  Agnieszka Wąsik; Irena Romańska; Jerzy Michaluk; Małgorzata Kajta; Lucyna Antkiewicz-Michaluk
Journal:  Neurotox Res       Date:  2014-05-20       Impact factor: 3.911

5.  Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson's Disease.

Authors:  Agnieszka Wąsik; Irena Romańska; Jerzy Michaluk; Agnieszka Zelek-Molik; Irena Nalepa; Lucyna Antkiewicz-Michaluk
Journal:  Neurotox Res       Date:  2015-08-25       Impact factor: 3.911

Review 6.  Medicinal chemistry perspectives of 1,2,3,4-tetrahydroisoquinoline analogs - biological activities and SAR studies.

Authors:  Banoth Karan Kumar; Kondapalli Venkata Gowri Chandra Sekhar; Subhash Chander; Selvaraj Kunjiappan; Sankaranarayanan Murugesan
Journal:  RSC Adv       Date:  2021-03-29       Impact factor: 4.036

7.  Concentration-dependent opposite effects of 1-benzyl-1,2,3,4-tetrahydroisoquinoline on markers of apoptosis: in vitro and ex vivo studies.

Authors:  Agnieszka Wąsik; Małgorzata Kajta; Tomasz Lenda; Lucyna Antkiewicz-Michaluk
Journal:  Neurotox Res       Date:  2013-11-05       Impact factor: 3.911

8.  Comparison of the Effects of Acute and Chronic Administration of Tetrahydroisoquinoline Amines on the In Vivo Dopamine Release: A Microdialysis Study in the Rat Striatum.

Authors:  Agnieszka Wąsik; Irena Romańska; Lucyna Antkiewicz-Michaluk
Journal:  Neurotox Res       Date:  2016-08-27       Impact factor: 3.911

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.